StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.71+0.08 (+12.14%)

Close on Nov 18, 2026Market cap $5.36MP/E –Yield –

Cerenome price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Cerenome's price to book ratio was 1.1× on Nov 11, 2026, against 15.9× a year earlier. Over the last 5 years it ranged from 0.1× to 83.5×, with a median of 0.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×−12.3
2025Dec 31, 202513.3×+9.9
2024Jan 31, 20243.5×+0.4
2023Dec 29, 20233.0×+3.0
2022Dec 30, 20220.1×−0.0
2021Dec 31, 20210.1×−0.2
2020Dec 31, 20200.2×−2.6
2019Dec 31, 20192.8×+2.8
2018Dec 31, 20180.0×−0.1
2017Dec 29, 20170.1×−0.1
2016Dec 30, 20160.2×–

More Cerenome figures

See a number that looks wrong?